Brief: Aileron Therapeutics Reports Third Quarter 2022 Financial Results

Rein Therapeutics

01/11/2022 12:35

Nov 1 (Reuters) - Aileron Therapeutics Inc  ALRN.O :
    * AILERON THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND BUSINESS HIGHLIGHTS
    * AILERON THERAPEUTICS INC - CASH RUNWAY EXPECTED TO SUPPORT
OPERATIONS AND KEY MILESTONES THROUGH END OF 1Q 2024, INCLUDING
PLANNED BREAST CANCER TRIAL READOUTS IN 2023
    * AILERON THERAPEUTICS INC - DILUTED NET LOSS PER SHARE FOR
Q3 OF
2022 WAS $0.07
    * AILERON THERAPEUTICS INC - CASH, CASH EQUIVALENTS, AND
INVESTMENTS ON SEPTEMBER 30, 2022, WERE $25.5 MILLION, COMPARED
TO $45.9 MILLION ON DECEMBER 31, 2021

Source text for Eikon:  ID:nGNXb0w3Yw 
Further company coverage:  ALRN.O 
 ((Reuters.Briefs@thomsonreuters.com;))